This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, K P Articles by Fennie, E H Search for Related Content PubMed PubMed Citation Articles by Anderson, K P Articles by Fennie, E H

Adenovirus early region 1A modulation of interferon antiviral activity.

ABSTRACT

Human adenovirus type 5 (Ad5) is a DNA virus which replicates as efficiently in human A549 cells treated with human interferon-alpha 2 (IFN) as in untreated cells. Vesicular stomatitis virus (VSV), on the other hand, is a negative-strand RNA virus which is very sensitive to the effects of IFN treatment in A549 cells. The IFN-mediated inhibition of VSV replication was not observed in cells coinfected with Ad5. Abrogation of IFN-mediated antiviral activity was maximal when Ad5 infection preceded VSV infection by at least 36 h, but did not require adenovirus DNA synthesis for manifestation. Coinfection experiments with VSV and deletion variants of adenovirus demonstrated that neither virus-associated RNA synthesis nor expression of adenovirus early regions E1B, E2A, E3, or E4 are required for abrogation of IFN-mediated inhibition of VSV replication. However, expression of early region E1A was essential, suggesting that E1A products can modulate, either directly or indirectly, IFN activity in adenovirus-infected cells.

This article has been cited by other articles:

• LEEN, A. M., MYERS, G. D., BOLLARD, C. M., HULS, M. H., SILI, U., GEE, A. P., HESLOP, H. E., ROONEY, C. M. (2005). T-Cell Immunotherapy for Adenoviral Infections of Stem-Cell Transplant Recipients. Ann. N. Y. Acad. Sci. 1062: 104-115 [Abstract] [Full Text]  
• Tritel, M., Stoddard, A. M., Flynn, B. J., Darrah, P. A., Wu, C.-y., Wille, U., Shah, J. A., Huang, Y., Xu, L., Betts, M. R., Nabel, G. J., Seder, R. A. (2003). Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses. J. Immunol. 171: 2538-2547 [Abstract] [Full Text]  
• Routes, J. M., Ryan, S., Clase, A., Miura, T., Kuhl, A., Potter, T. A., Cook, J. L. (2000). Adenovirus E1A Oncogene Expression in Tumor Cells Enhances Killing by TNF-Related Apoptosis-Inducing Ligand (TRAIL). J. Immunol. 165: 4522-4527 [Abstract] [Full Text]  
• Smith, K., Brown, C. C., Spindler, K. R. (1998). The Role of Mouse Adenovirus Type 1 Early Region 1A in Acute and Persistent Infections in Mice. J. Virol. 72: 5699-5706 [Abstract] [Full Text]  
• Constantoulakis, P, Campbell, M, Felber, B., Nasioulas, G, Afonina, E, Pavlakis, G. (1993). Inhibition of Rev-mediated HIV-1 expression by an RNA binding protein encoded by the interferon-inducible 9-27 gene. Science 259: 1314-1318 [Abstract]